journal
Journals Endocrinology and Metabolism C...

Endocrinology and Metabolism Clinics of North America

https://read.qxmd.com/read/38272591/acute-and-chronic-adverse-outcomes-of-type-1-diabetes
#41
REVIEW
Rachel Longendyke, Jody B Grundman, Shideh Majidi
Type 1 diabetes is associated with both acute and chronic complications. Acute complications include diabetic ketoacidosis and severe hypoglycemia. Chronic complications can be microvascular or macrovascular. Microvascular complications include retinopathy, nephropathy, and neuropathy. The pathophysiology of microvascular complications is complex. Hyperglycemia is a common underlying risk factor, underscoring the importance of optimizing glycemic management. Patients with type 1 diabetes are also at increased risk of macrovascular complications including coronary artery disease and vascular disease...
March 2024: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/38272590/psychosocial-care-for-youth-with-type-1-diabetes-summary-of-reviews-to-inform-clinical-practice
#42
REVIEW
Jenna B Shapiro, Kimberly P Garza, Marissa A Feldman, Madeleine C Suhs, Julia Ellis, Amanda Terry, Kelsey R Howard, Jill Weissberg-Benchell
The intensive demands of diabetes care can be difficult for youth with type 1 diabetes and their families to integrate into daily life. Standards of care in pediatric diabetes highlight the importance of evidence-based psychosocial interventions to optimize self-management behaviors and psychological well-being. The current review summarizes select systematic reviews and meta-analyses on evidence-based behavioral health interventions in pediatric diabetes. Interventions include strategies to strengthen youth psychosocial skills, improve family dynamics and caregiver mental health, enhance health and mental health equity, and address psychosocial factors related to diabetes technology use...
March 2024: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/38272589/improving-outcomes-for-people-with-type-1-diabetes-through-collaboration-summary-of-type-1-diabetes-exchange-quality-improvement-collaborative-studies
#43
REVIEW
Osagie Ebekozien, Ann Mungmode, Holly Hardison, Robert Rapaport
Type 1 diabetes (T1D) management has evolved over the last decade. Innovations and groundbreaking research have paved the way for improved outcomes for people with T1D. One of the major T1D focused research network that has supported real-world research studies in the United States is the T1D Exchange Quality Improvement Collaborative (T1DX-QI) Network.T1DX-QI is a large multicenter network of 55 T1D clinics that uses quality improvement, health equity framework, and population health principles to improve outcomes for people with T1D...
March 2024: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/37865486/recognizing-and-addressing-health-inequities-in-endocrinology-and-diabetes
#44
EDITORIAL
Sherita Hill Golden, Rana Malek
No abstract text is available yet for this article.
December 2023: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/37865485/disparities-in-endocrinology-care
#45
EDITORIAL
Robert Rapaport
No abstract text is available yet for this article.
December 2023: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/37865484/hormonal-injustice-environmental-toxicants-as-drivers-of-endocrine-health-disparities
#46
REVIEW
Margaret C Weiss, Luyu Wang, Robert M Sargis
The toll of multiple endocrine disorders has increased substantially in recent decades, and marginalized populations bear a disproportionate burden of disease. Because of the significant individual and societal impact of these conditions, it is essential to identify and address all modifiable risk factors contributing to these disparities. Abundant evidence now links endocrine dysfunction with exposure to endocrine-disrupting chemicals (EDCs), with greater exposures to multiple EDCs occurring among vulnerable groups, such as racial/ethnic minorities, those with low incomes, and others with high endocrine disease burdens...
December 2023: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/37865483/sociodemographic-factors-in-pituitary-adenomas
#47
REVIEW
Adriana G Ioachimescu
Pituitary adenomas have been increasingly detected in recent years, especially in the older population. Black patients have a higher incidence than other racial groups. In patients with functioning tumors, presentation and comorbidities are influenced by age and sex, whereas the impact of ethnoracial background is unclear. Active surveillance recommendation and surgery refusal disproportionally affect Black and older patients. The likelihood of surgery at high-volume centers is lower for patients of Black or Hispanic background, uninsured or with lower socioeconomic status...
December 2023: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/37865482/disparities-in-access-to-high-volume-surgeons-and-specialized-care
#48
REVIEW
Terry P Gao, Rebecca L Green, Lindsay E Kuo
The significant volume-outcome relationship has triggered interest in improving quality of care by directing patients to high-volume centers and surgeons. However, significant disparities exist for different racial/ethnic, geographic, and socioeconomic groups for thyroid, parathyroid, adrenal, and pancreatic neuroendocrine surgical diseases disease.
December 2023: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/37865481/challenges-of-gender-affirming-care-in-incarcerated-transgender-people
#49
REVIEW
Rana Malek, Mauro Sarmiento, Elizabeth Lamos
Social and health disparities among transgender people may result in increased rates of incarceration, particularly among Black transgender women. The World Professional Association for Transgender Health states that all recommendations for gender-affirming care made in the Standards of Care-8 be applied equally to people living in institutions. Understanding the structural challenges to gender-affirming care in the corrections environment will allow the endocrinologist to navigate the complex correctional health care system...
December 2023: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/37865480/racial-and-ethnic-disparities-in-access-to-and-outcomes-of-infertility-treatment-and-assisted-reproductive-technology-in-the-united-states
#50
REVIEW
Gabriela Beroukhim, David B Seifer
Infertility disproportionately affects the minority, non-White populace, with Black women having twofold higher odds than White women. Despite higher infertility rates, minority racial and ethnic groups access and utilize fertility care less frequently. Even once care is accessed, racial and ethnic disparities exist in infertility treatment and ART outcomes. Preliminary studies indicate that Asian and American Indian women have lower intrauterine insemination pregnancy rates. Many robust studies indicate significant racial and ethnic disparities in rates of clinical pregnancy, live birth, pregnancy loss, and obstetrical complications following in vitro fertilization, with lower favorable outcomes in Black, Asian, and Hispanic women...
December 2023: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/37865479/global-health-disparities-in-childhood-rickets
#51
REVIEW
Alicia Diaz-Thomas, Pallavi Iyer
Nutritional rickets is a global health problem reflecting both historical and contemporary health disparities arising from racial, ethnic, environmental, and geopolitical circumstances. It primarily affects marginalized populations and can contribute to long-term morbidity. Deficits in bone health in childhood may also contribute to osteomalacia/osteoporosis. Solutions require a global public health approach.
December 2023: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/37865478/racial-and-ethnic-disparities-in-metabolic-bone-disease
#52
REVIEW
Lauren Y Maldonado, Linette Bosques, Sara J Cromer, Sharl S Azar, Elaine W Yu, Sherri-Ann M Burnett-Bowie
Racial and ethnic disparities exist in the prevalence and management of osteoporosis, metastatic cancer, and sickle cell disease. Despite being the most common metabolic bone disease, osteoporosis remains underscreened and undertreated among Black women. Skeletal-related events in metastatic cancer include bone pain, pathologic fractures, and spinal cord compression. Disparities in screening for and treating skeletal-related events disproportionately affect Black patients. Metabolic bone disease contributes significantly to morbidity in sickle cell disease; however, clinical guidelines for screening and treatment do not currently exist...
December 2023: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/37865477/equity-in-obesity-review
#53
REVIEW
Karla N Kendrick, Kevin J Bode Padron, Nichola Z Bomani, Jashalynn C German, Dennis D Nyanyo, Brenda Varriano, Lucy Tu, Fatima Cody Stanford
Obesity disproportionately affects racial and ethnic minoritized populations and those of lower socioeconomic status. Similarly, disparities exist in the development of its downstream consequences, such as type 2 diabetes and hypertension. The causes of these disparities are multifactorial and are influenced by structural factors such as segregation and healthcare access, and individual-level factors such as weight stigma. Interventions to decrease disparities in obesity should consider macro-level, community, and individual-level factors that might reduce disparities and improve equity in obesity care...
December 2023: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/37865476/diabetes-care-in-humanitarian-settings
#54
REVIEW
Sylvia Kehlenbrink, Kiran Jobanputra, Amulya Reddy, Philippa Boulle, Apoorva Gomber, Rachel Nugent, Vinod Varma, Anna T Nakayama, Tom Ellman
Despite the increasing prevalence of diabetes in populations experiencing humanitarian crisis, along with evidence that people living with diabetes are at higher risk for poor outcomes in a crisis, diabetes care is not routinely included in humanitarian health interventions. We here describe 4 factors that have contributed to the inequities and lack of diabetes inclusion in humanitarian programmes: (1) evolving paradigms in humanitarian health care, (2) complexities of diabetes service provision in humanitarian settings, (3) social and cultural challenges, and (4) lack of financing...
December 2023: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/37865475/interventions-across-the-translational-research-spectrum-addressing-disparities-among-racial-and-ethnic-minoritized-youth-with-type-1-diabetes
#55
REVIEW
Deborah A Ellis, Sylvie Naar
Racial and ethnic minoritized youth with type 1 diabetes (T1D) are at elevated risk for health disparities. Few intervention studies have been conducted for these youth and evidence to support best practices to address their needs is lacking. Existing evidence supports the use of brief trials of diabetes technology with structured support from clinic staff, culturally tailored interventions such as language-congruent clinical care, and use of community health workers as promising directions to improve health outcomes...
December 2023: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/37865474/peer-support-to-enhance-type-2-diabetes-prevention-among-african-american-and-latino-adults
#56
REVIEW
Irving Ling, Ruth Enid Zambrana, Sandra Echeverria, Lenny López
Social support occurs within complex social networks that are diffusely embedded within the social determinants of health. Social networks operate through five primary interconnected pathways: (1) provision of social support; (2) social influence; (3) social engagement; (4) social capital; and (5) social cohesion. Research has demonstrated that increased social support can have a beneficial impact on Type 2 Diabetes (T2DM) prevention and outcomes through culturally tailored Diabetes Prevention Programs in minority communities...
December 2023: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/37865473/advancing-equity-in-diabetes-prevention-treatment-and-outcomes-delivering-on-our-values
#57
REVIEW
Joshua J Joseph
Diabetes inequities exist from diabetes prevention to outcomes and are rooted in the social drivers (determinants) of health. Historical policies such as "redlining" have adversely affected diabetes prevalence, control, and outcomes for decades. Advancing diabetes equity requires multimodal approaches, addressing both individual-level diabetes education, self-management, and treatment along with addressing social needs, and working to improve upstream drivers of health. All individuals affected by diabetes must advocate for policies to advance diabetes equity at the organizational, local, state, and federal levels...
December 2023: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/37495346/metabolic-associated-fatty-liver-disease-a-disastrous-human-health-challenge
#58
EDITORIAL
Sherouk Fouda, Joseph M Pappachan
The pathobiology of MAFLD is such a big puzzle, and many of the metabolic and other health consequences of the disease are not yet fully elucidated. In their review on "Pathobiology of metabolic-associated fatty liver disease," Fouda and colleagues update the current evidence on the disease characteristics. The prevalence of MAFLD has reached epidemic proportions in children and young adults in the recent years, with figures reaching as high as 15% owing to the global obesity pandemic. Vespoli and colleagues in their review "MAFLD in childhood and adolescence" portray the latest updates and new emerging therapies for pediatric MAFLD...
September 2023: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/37495345/endocrinology-and-fatty-liver-disease
#59
EDITORIAL
Robert Rapaport
No abstract text is available yet for this article.
September 2023: Endocrinology and Metabolism Clinics of North America
https://read.qxmd.com/read/37495344/management-of-metabolic-associated-fatty-liver-disease
#60
REVIEW
Kirthika Venkatesan, Nisha Nigil Haroon
Metabolic-associated fatty liver disease (MAFLD), previously known as nonalcoholic fatty liver disease (NAFLD), is the most common cause of liver disease in the world. Its prevalence is over 30% and is becoming the most common cause of liver transplants. Rates are rising along with obesity-related diseases. Risk factors for MAFLD include adverse lifestyles, genetic variations, advancing age, male sex, and alterations in the gut microbiota. Extrahepatic complications include cardiovascular disease, renal dysfunction, and colorectal cancer...
September 2023: Endocrinology and Metabolism Clinics of North America
journal
journal
29717
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.